Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 6Head & Neck 3Other hematologic neoplasm 2Lymphoid 2Gastrointestinal 2Sarcoma 1Plasma cell 1Breast 1

Conditions

Lymphoma 152Precursor Cell Lymphoblastic Leukemia-Lymphoma 93Lymphoma, Follicular 81Lymphoma, Large B-Cell, Diffuse 80Leukemia 79Lymphoma, Non-Hodgkin 75Hodgkin Disease 74Burkitt Lymphoma 67Leukemia, Lymphocytic, Chronic, B-Cell 63Lymphoma, Large-Cell, Immunoblastic 58Lymphoma, Mantle-Cell 53Lymphoma, B-Cell, Marginal Zone 52Myelodysplastic Syndromes 40Leukemia, Myeloid, Chronic-Phase 36Leukemia, Myeloid, Acute 36Dendritic Cell Sarcoma, Interdigitating 33Leukemia, Myeloid, Accelerated Phase 32Neoplasms, Plasma Cell 30Multiple Myeloma 30Recurrence 28Blast Crisis 23Myeloproliferative Disorders 22Congenital Abnormalities 21Leukemia, Myelomonocytic, Chronic 20Mycosis Fungoides 19Myelodysplastic-Myeloproliferative Diseases 17Lymphoma, Large-Cell, Anaplastic 17Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 17Graft vs Host Disease 17Waldenstrom Macroglobulinemia 16

Interventions

Cyclophosphamide 5Etoposide 4Cytarabine 3sargramostim 2denileukin diftitox 2Radiotherapy 2Filgrastim 2Dexamethasone 2Carboplatin 2Amifostine 2sodium thiosulfate 1pegfilgrastim 1pegaspargase 1glucarpidase 1etoposide phosphate 1Vincristine 1Silymarin 1Rituximab 1Prednisolone 1Phenobarbital 1Methylprednisolone 1Methotrexate 1Mercaptopurine 1Leucovorin 1Irinotecan 1Ifosfamide 1Hydrocortisone 1Granulocyte Colony-Stimulating Factor 1Fibroblast Growth Factor 7 1Epoetin Alfa 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Drug-Related Side Effects and Adverse Reactions × Radiotherapy × Lymphoid × Clear all
NCT00400946 2026-02-13

05-001: Treatment of Acute Lymphoblastic Leukemia in Children

Dana-Farber Cancer Institute

Phase 3 Completed
800 enrolled 22 charts
LymphoidOther hematologic neoplasm

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Drug-Related Side Effects and Adverse Reactions

NCT00004132 2013-06-26

Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer

National Cancer Institute (NCI)

Phase 2 Completed
LymphoidOther hematologic neoplasmPlasma cellSarcoma

Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Radiation Injuries, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Dendritic Cell Sarcoma, Interdigitating, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡